Table 4 Comparison of selected model inputs from Ge et al. [13] and Genders et al. [20]
Variable | Genders 2015 value [20] | Genders source(s) | Ge 2020 value [13] | Ge source(s) |
|---|---|---|---|---|
CMR sensitivity | 0.89 | Jaarsma et al. [37] | 0.89 | Knuuti et al. [8] |
CMR specificity | 0.76 | Jaarsma et al. [37] | 0.87 | Knuuti et al. [8] |
CMR cost | $621 | CPT 75563 and 93015 | $807 | CMS |
CCTA sensitivity | 0.98 | Mowatt et al. [34], Scheutz et al. [36], von Ballmoos et al. [35] | 0.90 | Danad et al. [7] |
CCTA specificity | 0.89 | Mowatt et al. [34], Scheutz et al. [36], von Ballmoos et al. [35] | 0.71 | Danad et al. [7] |
CCTA cost (includes FFR for some patients) | $372 | CPT 75574 | $981 | CMS |
Age (years) | 60 | Assumption | 62.5 | Kwong et al. [46] |
ICA cost | $2989 | CPT 93454 | $3941 | CMS |
CABG cost | $38,217 | AHRQ 2011 | $38,797 | O’Sullivan et al. [47] |
PCI cost | $6529 | CPT 92980 | $36,556 | O’Sullivan et al. [47] |
Prevalence of CAD | 0.30 | Nieman et al. [48] | 32.4% | Kwong et al. [46] |
Proportion male | Sex-specific analyses | Not applicable | 53% | Kwong et al. [46] |